CHANTHA SCOTT: Open Payments
NPI 1952952459 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 33 payments from 13 companies in 2025. Trend: 2023 $212 · 2024 $1,029 · 2025 $725
Food & beverage: $725
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $159 |
| United Therapeutics Corporation | 3 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $74 |
| Alnylam Pharmaceuticals Inc. | 3 | $65 |
| BridgeBio Pharma, Inc. | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| PFIZER INC. | 2 | $56 |
| Novo Nordisk Inc | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
Products named: WINREVAIR, ONPATTRO, Tyvaso, Attruby, VYNDAQEL, Kerendia, VERQUVO, FARXIGA.
Industry payments across NC — which companies pay providers there.
